Chinese BE GL [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2020-12-30 13:16 (768 d 17:43 ago) – Posting: # 22162
Views: 1,486

Hi ElMaestro,

❝ Yes the website is a kind of challenge for the liguistically imparied, such as myself.


Welcome to the club.

❝ Here's a cheat proposal: Go to the Taiwanese regulator, and find this document.


THX, but I’m looking for [image] not [image] …

Acc. to this post China follows the FDA’s RSABE. I have only the Chinese Pharmacopia of 2015 (EMA’s ABEL) and the BE-GL of 2016 (nothing about HVDs).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
30 visitors (0 registered, 30 guests [including 12 identified bots]).
Forum time: 07:00 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5